⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INMB News
INmune Bio Inc. Common stock
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
globenewswire.com
INMB
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
globenewswire.com
INMB
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
globenewswire.com
INMB
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
globenewswire.com
INMB
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
globenewswire.com
INMB